272 related articles for article (PubMed ID: 33067756)
21. Comparing the properties of the EQ-5D-5L and EQ-5D-3L in general population in Iran.
Rezaei S; Woldemichael A; Ahmadi S; Mohamadi Bolbanabad A; Zahir Abdullah F; Piroozi B
Int J Health Plann Manage; 2021 Sep; 36(5):1613-1625. PubMed ID: 34013594
[TBL] [Abstract][Full Text] [Related]
22. Psychometric properties of the EQ-5D-5L in patients with hip or knee osteoarthritis: reliability, validity and responsiveness.
Bilbao A; García-Pérez L; Arenaza JC; García I; Ariza-Cardiel G; Trujillo-Martín E; Forjaz MJ; Martín-Fernández J
Qual Life Res; 2018 Nov; 27(11):2897-2908. PubMed ID: 29978346
[TBL] [Abstract][Full Text] [Related]
23. Validation and comparison of 15-D and EQ-5D-5L instruments in a Spanish Parkinson's disease population sample.
García-Gordillo M; del Pozo-Cruz B; Adsuar JC; Sánchez-Martínez FI; Abellán-Perpiñán JM
Qual Life Res; 2014 May; 23(4):1315-26. PubMed ID: 24258254
[TBL] [Abstract][Full Text] [Related]
24. Validity of EQ-5D-5L in stroke.
Golicki D; Niewada M; Buczek J; Karlińska A; Kobayashi A; Janssen MF; Pickard AS
Qual Life Res; 2015 Apr; 24(4):845-50. PubMed ID: 25347978
[TBL] [Abstract][Full Text] [Related]
25. Inter-rater reliability of care home staff's proxy judgements with residents' assessments of their own health-related quality of life: an analysis of the PATCH trial EQ-5D data.
Kelly C; Hulme C; Graham L; Ellwood A; Patel I; Cundill B; Farrin A; Goodwin M; Hull K; Fisher J; Forster A
Age Ageing; 2021 Jun; 50(4):1314-1320. PubMed ID: 33822852
[TBL] [Abstract][Full Text] [Related]
26. Comparison of EQ-5D-5L and SPVU-5D for measuring quality of life in patients with venous leg ulcers in an Australian setting.
Cheng Q; Kularatna S; Lee XJ; Graves N; Pacella RE
Qual Life Res; 2019 Jul; 28(7):1903-1911. PubMed ID: 30778889
[TBL] [Abstract][Full Text] [Related]
27. Comparison between EQ-5D-5L and PROMIS-10 to evaluate health-related quality of life 3 months after stroke: a cross-sectional multicenter study.
DE Graaf JA; Visser-Meily JM; Schepers VP; Baars A; Kappelle LJ; Passier PE; Wermer MJ; DE Wit DC; Post MW
Eur J Phys Rehabil Med; 2021 Jun; 57(3):337-346. PubMed ID: 33448750
[TBL] [Abstract][Full Text] [Related]
28. Linguistic and Psychometric Validation of the Cognition Bolt-On Version of the Japanese EQ-5D-5L for the Elderly.
Igarashi A; Sakata Y; Azuma-Kasai M; Kamiyama H; Kawaguchi M; Tomita K; Ishii M; Ikeda M
J Alzheimers Dis; 2023; 91(4):1447-1458. PubMed ID: 36641680
[TBL] [Abstract][Full Text] [Related]
29. Testing measurement properties of two EQ-5D youth versions and KIDSCREEN-10 in China.
Pei W; Yue S; Zhi-Hao Y; Ruo-Yu Z; Bin W; Nan L
Eur J Health Econ; 2021 Sep; 22(7):1083-1093. PubMed ID: 33893889
[TBL] [Abstract][Full Text] [Related]
30. Comparison of quality of life measurements: EQ-5D-5L versus disease/treatment-specific measures in pulmonary embolism and deep vein thrombosis.
Chuang LH; Cohen AT; Agnelli G; Gumbs PD; Bauersachs R; Kroep S; Gitt AK; Monreal M; Willich SN; van Hout B
Qual Life Res; 2019 May; 28(5):1155-1177. PubMed ID: 30607785
[TBL] [Abstract][Full Text] [Related]
31. Mapping the SRS-22r questionnaire onto the EQ-5D-5L utility score in patients with adolescent idiopathic scoliosis.
Wong CKH; Cheung PWH; Samartzis D; Luk KD; Cheung KMC; Lam CLK; Cheung JPY
PLoS One; 2017; 12(4):e0175847. PubMed ID: 28414745
[TBL] [Abstract][Full Text] [Related]
32. Convergent validation of EQ-5D-5L in patients with Parkinson's disease.
Alvarado-Bolaños A; Cervantes-Arriaga A; Rodríguez-Violante M; Llorens-Arenas R; Calderón-Fajardo H; Millán-Cepeda R; Leal-Ortega R; Estrada-Bellmann I; Zuñiga-Ramírez C
J Neurol Sci; 2015 Nov; 358(1-2):53-7. PubMed ID: 26276513
[TBL] [Abstract][Full Text] [Related]
33. Assessing validity of the EQ-5D-5L proxy in children and adolescents with Duchenne muscular dystrophy or spinal muscular atrophy.
Xu RH; Dai Y; Ng SSM; Tsang HWH; Zhang S; Dong D
Eur J Health Econ; 2024 Feb; 25(1):103-115. PubMed ID: 36809586
[TBL] [Abstract][Full Text] [Related]
34. A pilot study on the validity and psychometric properties of the electronic EQ-5D-5L in routine clinical practice.
Lam CLK; Tse ETY; Wong CKH; Lam JSM; Chen SS; Bedford LE; Cheung JPY; Or CK; Kind P
Health Qual Life Outcomes; 2021 Dec; 19(1):266. PubMed ID: 34922564
[TBL] [Abstract][Full Text] [Related]
35. Investigating the Added Value of the EQ-5D-5L With Two Bolt-On Items in Patients With Hemophilia.
Xu RH; Dong D; Luo N; Yang R; Liu J; Zhang S
Front Med (Lausanne); 2021; 8():707998. PubMed ID: 34422863
[No Abstract] [Full Text] [Related]
36. Assessing the psychometric performance of EQ-5D-5L in dementia: a systematic review.
Keetharuth AD; Hussain H; Rowen D; Wailoo A
Health Qual Life Outcomes; 2022 Sep; 20(1):139. PubMed ID: 36171595
[TBL] [Abstract][Full Text] [Related]
37. Comparing the EQ-5D-5L and stroke impact scale 2.0 in stroke patients: an analysis of measurement properties.
Schmidt J; Düvel JA; Elkenkamp S; Greiner W
Health Qual Life Outcomes; 2024 Jun; 22(1):45. PubMed ID: 38835023
[TBL] [Abstract][Full Text] [Related]
38. Validity of EQ-5D-5L, Skindex-16, DLQI and DLQI-R in patients with hidradenitis suppurativa.
Gergely LH; Gáspár K; Brodszky V; Kinyó Á; Szegedi A; Remenyik É; Kiss NF; Bató A; Péntek M; Gulácsi L; Sárdy M; Bánvölgyi A; Wikonkál N; Rencz F
J Eur Acad Dermatol Venereol; 2020 Nov; 34(11):2584-2592. PubMed ID: 32618022
[TBL] [Abstract][Full Text] [Related]
39. Examining the relationship between the Short Warwick-Edinburgh Mental Well-being Scale (SWEMWBS) and EQ-5D-5L and comparing their psychometric properties.
Hong Y; Jiang X; Zhang T; Luo N; Yang Z
Health Qual Life Outcomes; 2023 Mar; 21(1):25. PubMed ID: 36927468
[TBL] [Abstract][Full Text] [Related]
40. The construct validity and responsiveness of the EQ-5D-5L, AQL-5D and a bespoke TTO in acute asthmatics.
Crossman-Barnes CJ; Sach T; Wilson A; Barton G
Qual Life Res; 2020 Mar; 29(3):619-627. PubMed ID: 31676971
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
